Publication:
Acta Pharmaceutica Volume 73
Acta Pharmaceutica Volume 73
No Thumbnail Available
Files
Date
2023
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Abstract
(Xanthoxyletin blocks the RANK/RANKL signaling pathway to
suppress the growth of human pancreatic cancer cells - https://doi.org/10.2478/acph-2023-0024) -
(A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative
inhibits cell proliferation by suppressing the MEK/ERK
signaling pathway in colorectal cancer - https://doi.org/10.2478/acph-2023-0025) -
(Scoulerine promotes cytotoxicity and attenuates stemness
in ovarian cancer by targeting PI3K/AKT/mTOR axis - https://doi.org/10.2478/acph-2023-0021) -
(Formulation and optimization of polymeric nanoparticles
loaded with riolozatrione: a promising nanoformulation with
potential antiherpetic activity - https://doi.org/10.2478/acph-2023-0028) -
(Design and synthesis of amino-substituted N-arylpiperidinyl-
-based inhibitors of the (immuno)proteasome - https://doi.org/10.2478/acph-2023-0032) -
(Astragaloside IV inhibits pathological functions
of gastric cancer-associated fibroblasts through regulation
of the HOXA6/ZBTB12 axis - https://doi.org/10.2478/acph-2023-0033) -
(Influence of fused deposition modelling printing
parameters on tablet disintegration times: a design
of experiments study - https://doi.org/10.2478/acph-2023-0026) -
(Insights into the formulation properties, biocompatibility,
and permeability of poorly water-soluble methoxyflavones
with PEG400 and propylene glycol - https://doi.org/10.2478/acph-2023-0030) -
(Rosuvastatin effects on the HDL proteome
in hyperlipidemic patients - https://doi.org/10.2478/acph-2023-0034)